advances in the management of bph n.
Skip this Video
Loading SlideShow in 5 Seconds..
Advances in the Management of BPH PowerPoint Presentation
Download Presentation
Advances in the Management of BPH

Loading in 2 Seconds...

play fullscreen
1 / 29

Advances in the Management of BPH - PowerPoint PPT Presentation

  • Uploaded on

Advances in the Management of BPH. Mr C Dawson Consultant Urologist Edith Cavell Hospital Peterborough. Advances in the Management of BPH. Mr C Dawson Consultant Urologist Fitzwilliam Hospital Peterborough. The Scale of the Problem.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Advances in the Management of BPH' - nicholas-simmons

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
advances in the management of bph

Advances in the Management of BPH

Mr C Dawson

Consultant Urologist

Edith Cavell Hospital


advances in the management of bph1

Advances in the Management of BPH

Mr C Dawson

Consultant Urologist

Fitzwilliam Hospital


the scale of the problem
The Scale of the Problem
  • Moderate to severe Lower Urinary Tract Symptoms (LUTS) occur in 25% of men over 50 years, and the incidence rises with age
  • Approximately 90% of men will develop histological evidence of BPH by 80 years of age
the scale of the problem1
The Scale of the Problem

Increasing because:

  • Men are living longer
  • Proportion of Men over 50 years will increase
  • Men are better informed about health matters
difficulties in diagnosis and management
Difficulties in Diagnosis and Management
  • The symptoms of BPH are the same as those of early Prostate Cancer
  • Confirmation of the presence of prostate cancer may be difficult
  • The need to treat (proven) cancer may not always be clear cut
understanding lower urinary tract symptoms after abrams bristol uk
Storage Symptoms




Urge incontinence

Bladder Pain

Understanding Lower Urinary Tract Symptoms (after Abrams, Bristol, UK)
  • Voiding Symptoms
  • Slow stream
  • Intermittent flow
  • Hesitancy
  • Straining
  • Terminal dribble
physical signs
Physical Signs
  • May be few
  • Look for obvious uraemia
  • Palpate for full bladder
  • Examine urethral meatus and palpate urethra for stricture
investigations for bph
Investigations for BPH
  • Urea and electrolytes if clinically indicated
  • PSA (should we counsel patients?)
  • Ultrasound urogram
  • Flow rate (if you have access)
  • IPSS
a word about prostate cancer
A word about Prostate Cancer
  • No symptoms specificfor early prostate cancer
  • Presenting symptoms are therefore those of BPH
  • Biopsy of the prostate should be performed in those with abnormal DRE, or PSA above age-specific reference range
prostate specific antigen
Prostate Specific Antigen
  • Single-chain glycoprotein of 240 aa residues and 4 carbohydrate side chains
  • Physiological role in lysis of seminal coagulum
  • Prostate specific, but NOT cancer specific
prostate specific antigen1
Prostate Specific Antigen

In addition to prostate cancer, an elevated level may be found in

  • Increasing age
  • Acute urinary retention / Catheterisation
  • after TURP / Prostate Biopsy
  • Prostatitis
  • BPH

A reduced level may be found in patients treated with Finasteride

the problem with psa
The Problem with PSA
  • Men with Prostate Cancer may have a normal PSA
  • Men with BPH or other benign conditions may have a raised PSA
  • May not even be prostate-specific!
  • What to do with men with a PSA of 4-10 ng/ml

PSA = Persistent Source of Anxiety?

refinements in the use of psa
Refinements in the use of PSA
  • PSA density
  • PSA Velocity
  • Age-Specific PSA

40-49 Years old <2.5ng/ml

50-59 Years old <3.5ng/ml

60-69 Years old <4.5ng/ml

70-79 Years old <6.5ng/ml

  • Free:Total PSA ratio (<0.15 strongly suggests possibility of Ca Prostate)
prostate specific antigen2
Prostate Specific Antigen




the management of bph
The Management of BPH
  • Advances in the Management of BPH
new treatment modalities for bph
New treatment modalities for BPH
  • -blocker therapy (including selective blockers of -1a receptors)
  • 5- -reductase inhibitors - Finasteride (Proscar)
  • Minimally invasive Techniques
    • Transurethral Microwave Thermotherapy (TUMT)
    • Transurethral Needle ablation (TUNA)
    • Transrectal high-intensity focused ultrasound (HiFU)
    • Transurethral electrovaporisation (TUVP)
pharmacotherapy for bph
Pharmacotherapy for BPH
  • Alpha-blockers remain an important therapy
  • Selective -1a receptor blockers may have fewer side effects
pharmacotherapy for bph1
Pharmacotherapy for BPH
  • Finasteride (Proscar) - PLESS study has confirmed that men with large prostates (>40cc), taking long-term therapy, less likely to develop acute retention, or require surgical intervention
minimally invasive therapies
Minimally invasive therapies
  • High energy TUMT, and TUNA, have proven clinical efficacy between that of drug therapy and TUVP or laser therapy
  • HiFU currently requires GA, is costly and time consuming, and appears unlikely to be popular at present
  • The subjective response after MITs and TURP appear similar, but objective results superior for TURP
surgical therapies
Surgical Therapies
  • TURP still the gold standard therapy, with which all other therapies must be considered
  • Laser therapy
    • expensive to set up
    • Significantly reduced blood loss
    • Catheter may be required post operatively
  • Open Prostatectomy rarely required
ech urology department guidelines for the management of bph
ECH Urology Department Guidelines for the Management of BPH
  • Produced after discussion between working party of General Practitioners and Consultants
  • Agreed within the department of Urology
future perspectives for the management of bph
Future perspectives for the management of BPH
  • Much more emphasis on Quality of Life
  • Minimally invasive therapies are improving and may yet challenge the superiority of TURP
conclusions bph
Conclusions - BPH
  • Remains an important cause of patient morbidity
  • Correct approach to assessment is important
  • Many men may have their symptoms relieved by alpha blocker therapy or Finasteride, which has also been shown to reduce the likelihood of surgery or acute urine retention
conclusions bph1
Conclusions - BPH
  • A large variety of MITs exist for BPH who fail drug therapy, but for most patients the gold standard surgical procedure remains TURP
  • The next few years will see many more techniques available to challenge the position of TURP